Insights into elevated distortion product otoacoustic emissions in sickle cell disease: Comparisons of hydroxyurea-treated and non-treated young children

Hearing Research

Volumn 212, Issue 1-2, 2006, Pages 83-89

  Stuart, Andrew ^a   Jones, Sherri M ^a   Walker, Letitia J ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b MISSOURI STATE UNIVERSITY   (United States)

Author keywords

Distortion product otoacoustic emissions; Hydroxyurea; Sickle cell disease

Indexed keywords

HEMOGLOBIN; HYDROXYUREA;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEARING LOSS; HUMAN; INFLAMMATORY DISEASE; MALE; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; SYMPTOM;

ADOLESCENT; ANTISICKLING AGENTS; AUDITORY THRESHOLD; CASE-CONTROL STUDIES; CHILD; COCHLEA; FEMALE; HEMOGLOBIN SC DISEASE; HUMANS; HYDROXYUREA; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS;

EID: 32844461701     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2005.10.014     Document Type: Article

References (76)

1. P.F. Adams, and V. Benson Current estimates from the National Health Interview Survey, 1991 Vital Health Stat. 10 184 1992 1 232
2. S.O. Ajulo, A.I. Osiname, and H.M. Myatt Sensorineural hearing loss in sickle cell anaemia - a United Kingdom study J. Laryngol. Otol. 107 1993 790 794
3. American National Standards Institute, 1996. Specifications for Audiometers. (ANSI S3.6-1996). ANSI, New York.
4. American National Standards Institute, 1999. Permissible Ambient Noise Levels For Audiometric Test Rooms. (ANSI S3.1-1999). ANSI, New York.
5. American Speech-Language-Hearing Association Panel on Audiologic Assessment, 1997. Guidelines for audiologic screening. ASHA, Rockville Pike, MD.
6. A. Ashoor, and B. Al-Awamy Sensorineural hearing loss in sickle cell disease patients in Saudi Arabia Trop. Geogr. Med. 37 1985 314 318
7. K. Atsina, and G. Ankra-Badu Sensorineural hearing loss in Ghanaians with sickle cell anaemia Trop. Geogr. Med. 40 1988 205 208
8. J.D. Belcher, C.J. Bryant, J. Nguyen, P.R. Bowlin, M.C. Kielbik, J.C. Bischof, R.P. Hebbel, and G.M. Vercellotti Transgenic sickle mice have vascular inflammation Blood 101 2003 3953 3959
9. M. Benkerrou, C. Delarche, L. Brahimi, M. Fay, E. Vilmer, J. Elion, M.A. Gougerot-Pocidalo, and C. Elbim Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia Blood 99 2002 2297 2303
10. C.I. Berlin, L.J. Hood, R.P. Cecola, D.F. Jackson, and P. Szabo Does type I afferent neuron dysfunction reveal itself through lack of afferent suppression? Hear. Res. 65 1993 40 50
11. C.I. Berlin, L. Hood, A. Hurley, and H. Wen Contralateral suppression of otoacoustic emissions: an index of the function of the medial olivocochlear system Otolaryngol. Head Neck Surg. 110 1994 3 21
12. M.D. Brown, T.M. Wick, and J.R. Eckman Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells Pediatr. Pathol. Mol. Med. 20 2001 47 72
13. M. Brun, S. Bourdoulous, P.O. Couraud, J. Elion, R. Krishnamoorthy, and C. Lapoumeroulie Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells Pharmacogeno. J. 3 2003 215 226
14. M.J. Cevette, D. Drew, T.M. Webb, and M.S. Marion Cisplatin ototoxicity, increased DPOAE amplitudes, and magnesium deficiency. Distortion product otoacoustic emissions J. Am. Acad. Audiol. 11 2000 323 329
15. C. Chen, R.A. Skellett, M. Fallon, and R.P. Bobbin Additional pharmacological evidence that endogenous ATP modulates cochlear mechanics Hear Res. 118 1998 47 61
16. J.A.B. Chies, and N.B. Nardi Sickle cell disease: a chronic inflammatory condition Med Hypotheses 57 2001 46 50
17. N. Conran, A. Fattori, S.T. Saad, and F.F. Costa Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea Am. J. Hematol. 76 2004 343 347
18. M.R. Crawford, H.J. Gould, W.R. Smith, N. Beckford, W.R. Gibson, and L. Bobo Prevalence of hearing loss in adults with sickle cell disease Ear Hear. 12 1991 349 351
19. C.R. Downs, A. Stuart, and D. Holbert Distortion product otoacoustic emissions in normal-hearing African-American children with homozygous sickle cell disease J. Commun. Disord. 33 2000 111 129
20. M. Drexl, J. Henke, and M. Kossl Isoflurane increases amplitude and incidence of evoked and spontaneous otoacoustic emissions Hear Res. 194 2004 135 142
21. J.E. Elion, M. Brun, M.H. Odievre, C.L. Lapoumeroulie, and R. Krishnamoorthy Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium Hematol. J. 5 Suppl. 3 2004 S195 S198
22. B. Forman-Franco, G. Karayalcin, D.D. Mandel, and A.L. Abramson The evaluation of auditory function in homozygous sickle cell disease Otolaryngol. Head Neck Surg. 89 1982 850 856
23. E.M. Friedman, N.L.C. Luban, G.R. Herer, and I. Williams Sickle cell anemia and hearing Ann. Otolaryngol. 89 1980 342 347
24. S.A. Gaskill, and A.M. Brown The behavior of the acoustic distortion product, 2f1-f2, from the human ear and its relation to auditory sensitivity J. Acoust. Soc. Am. 88 1990 821 839
25. B. Gentry, P. Davis, and J. Dancer Failure rates of young patients with sickle cell disease on a hearing screening test Percept. Mot. Skills 84 1997 434
26. M.T. Gladwin, J.H. Shelhamer, F.P. Ognibene, M.E. Pease-Fye, J.S. Nichols, B. Link, D.B. Patel, M.A. Jankowski, L.K. Pannell, A.N. Schechter, and G.P. Rodgers Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease Br. J. Haematol. 116 2 2002 436 444
27. M.P. Gorga, S.T. Neely, B.M. Bergman, K.L. Beauchaine, J.R. Kaminski, J. Peters, L. Schulte, and W. Jesteadt Otoacoustic emissions from normal-hearing and hearing-impaired subjects: Distortion product responses J. Acoust. Soc. Am. 93 1993 2050 2060
28. M.P. Gorga, S.T. Neely, B.M. Bergman, K.L. Beauchaine, J.R. Kaminski, J. Peters, L. Schulte, and W. Jesteadt A comparison of transient-evoked and distortion product otoacoustic emissions in normal-hearing and hearing-impaired subjects J. Acoust. Soc. Am. 94 1993 2639 2648
29. M.P. Gorga, S.T. Neely, B. Ohlrich, B. Hoover, J. Redner, and J. Peters From laboratory to clinic: a large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss Ear Hear. 18 1997 440 455
30. C. Halsey, and I.A. Roberts The role of hydroxyurea in sickle cell disease Br. J. Haematol. 120 2003 177 186
31. H. Haupt, F. Scheibe, and C. Ludwig Changes in cochlear oxygenation, microcirculation and auditory function during prolonged general hypoxia Eur. Arch. Otrhinolaryngol. 250 1993 396 400
32. C.A. Hillery, M.C. Du, W.C. Wang, and J.P. Scott Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin Br. J. Haematol. 109 2000 322 327
33. Z.W. Huang, Y. Luo, Z. Wu, Z. Tao, R.O. Jones, and H.B. Zhao Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate J. Neurophysiol. 93 2005 2053 2061
34. H. Huynh, and L.S. Feldt Estimation of the Box correction for degrees of freedom from sample data in randomized block and split-plot designs J. Educational Stat. 1 1976 69 82
35. M. Jacobson, S. Kim, J. Romney, X. Zhu, and R.D. Frisina Contralateral suppression of distortion product otoacoustic emissions declines with age: a comparison of findings in CBA mice with human listeners Laryngoscope 113 2003 1707 1713
36. A. Kakigi, H. Hirakawa, N. Harel, R.J. Mount, and R.V. Harrison Basal cochlear lesions result in increased amplitude of otoacoustic emissions Audiol. Neurootol. 3 1998 361 372
37. D.K. Kaul, and R.P. Hebbel Hypoxia/reoxygenation causes inflammatory responses in transgenic sickle mice but not in normal mice J. Clin. Invest. 106 2000 411 420
38. D.T. Kemp Otoacoustic emissions, travelling waves and cochlear mechanisms Hear Res. 22 1986 95 104
39. D.T. Kemp Otoacoustic emissions, their origin in cochlear function, and use Br. Med. Bull. 63 2002 223 241
40. S. Kim, D.R. Frisina, and R.D. Frisina Effects of age on contralateral suppression of distortion product otoacoustic emissions in human listeners with normal hearing Audiol. Neurootol. 7 2002 348 357
41. B.P. Kimberley, I. Hernadi, A.M. Lee, and D.K. Brown Predicting pure tone thresholds in normal and hearing-impaired ears with distortion product emissions and age Ear Hear. 15 1994 199 209
42. K. Koga, N. Hakuba, F. Watanabe, M. Shudou, T. Nakagawa, and K. Gyo Transient cochlear ischemia causes delayed cell death in the organ of Corti: An experimental study in gerbils J. Comp. Neurol. 456 2003 105 111
43. A. Koussi, D.I. Zafeiriou, G. Kontzoglou, I. Tsatra, G. Noussios, and M. Athanassiou Hearing loss in children with sickle cell disease Acta. Otorhinolaryngol. Belg. 55 2001 235 239
44. S.G. Kujawa, T.J. Glattke, M. Fallon, and R.P. Bobbin A nicotinic-like receptor mediates suppression of distortion product otoacoustic emissions by contralateral sound Hear. Res. 74 1994 122 134
45. B.L. Lonsbury-Martin, F.P. Harris, B.B. Stagner, M.D. Hawkins, and G.K. Martin Distortion product emissions in humans. II. Relations to acoustic immittance and stimulus frequency and spontaneous otoacoustic emissions in normally hearing subjects Ann. Otol. Rhinol. Laryngol. 147 Suppl. 1990 15 29
46. B.L. Lonsbury-Martin, M.J. McCoy, M.L. Whitehead, and G.K. Martin Clinical testing of distortion product otoacoustic emissions Ear Hear. 14 1993 11 22
47. C.B. MacDonald, P.W. Bauer, L.C. Cox, and L. McMahon Otologic findings in a pediatric cohort with sickle cell disease Int. J. Pediatr. Otorhinolaryngol. 47 1999 23 28
48. T. Mom, F.F. Telischi, G.K. Martin, and B.L. Lonsbury-Martin Measuring the cochlear blood flow and distortion product otoacoustic emissions during reversible cochlear ischemia: A rabbit model Hear. Res. 133 1999 40 52
49. K.M. Morgenstein, and E.D. Manace Temporal bone histopathology in sickle cell disease Laryngoscope 79 1969 2172 2180
50. K.M. Nicol, C.M. Hackney, E.F. Evans, and S.R. Pratt Behavioural evidence for recovery of auditory function in guinea pigs following kanamycin administration Hear. Res. 61 1992 117 131
51. O. Odetoyinbo, and A. Adekile Sensorineural hearing loss in children with sickle cell anemia Ann. Otol. Rhinol. Laryngol. 96 1987 258 260
52. I. Okpala, Y. Daniel, R. Haynes, D. Odoemene, and J. Goldman Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells Eur. J. Haematol. 69 2002 135 144
53. P.A. Onakoya, O.G. Nwaorgu, and W.A. Shokunbi Sensorineural hearing loss in adults with sickle cell anemia Afr. J. Med. Med. Sci. 31 2002 21 24
54. C. O'Rourke, C. Driscoll, J. Kei, and V. Smyth A normative study of distortion product otoacoustic emissions in 6-year-old schoolchildren Int. J. Audiol. 41 2002 162 169
55. J.J. Owens, M.J. McCoy, B.L. Lonsbury-Martin, and G.K. Martin Otoacoustic emissions in children with normal ears, middle ear dysfunction, and ventilating tubes Am. J. Otol. 14 1993 34 40
56. O. Piltcher, L. Cigana, J. Friedriech, F.A. Ribeiro, and S.S. da Costa Sensorineural hearing loss among sickle cell disease patients from southern Brazil Am. J. Otolaryngol. 21 2000 75 79
57. B.A. Prieve, T.S. Fitzgerald, L.E. Schulte, and D.T. Kemp Basic characteristics of distortion product otoacoustic emissions in infants and children J. Acoust. Soc. Am. 102 1997 2871 2879
58. E. Raveh, R.J. Mount, and R.V. Harrison Increased otoacoustic-emission amplitude secondary to cochlear lesions J. Otolaryngol. 27 1998 354 360
59. A.F. Ryan, J.P. Harris, and E.M. Keithley Immune-mediated hearing loss: basic mechanisms and options for therapy Acta Otolaryngol. Suppl. (Stockh.) 548 2002 38 43
60. A.W. Saleh, A.J. Duits, A. Gerbers, C. de Vries, and H.F. Hillen Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy Acta Haematol. 100 1998 26 31
61. A.W. Saleh, H.F. Hillen, and A.J. Duits Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy Acta Haematol. 102 1999 31 37
62. F. Scheibe, H. Haupt, and H. Baumgärtl Effects of experimental cochlear thrombosis on oxygenation and auditory function of the inner ear Eur. Arch. Otrhinolaryngol. 254 1997 91 94
63. J.M. Schweinfurth, and A.T. Cacace Cochlear ischemia induced by circulating iron particles under magnetic control: An animal model for sudden hearing loss Am. J. Otol. 21 2000 636 640
64. J.M. Schweinfurth, A.T. Cacace, and S.M. Parnes Clinical applications of otoacoustic emissions in sudden hearing loss Laryngoscope 107 1997 1457 1463
65. C.A. Shera Mechanisms of mammalian otoacoustic emission and their implications for the clinical utility of otoacoustic emissions Ear Hear. 25 2004 86 97
66. N.B. Slepecky Structure of the mammalian cochlea P. Dallos A.N. Popper R.R. Fay The Cochlea 1996 Springer-Verlag New York 44 129
67. M.J. Stuart, and R.L. Nagel Sickle cell disease Lancet 364 2004 1343 1360
68. L.A. Styles, B. Lubin, E. Vichinsky, S. Lawrence, M. Hua, S. Test, and F. Kuypers Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea Blood 89 1997 2554 2559
69. M. Suzuki, and J.P. Harris Expression of intercellular adhesion molecule-1 during inner ear inflammation Ann. Otol. Rhinol. Laryngol. 104 1995 69 75
70. C.L. Talmadge, G.R. Long, W.J. Murphy, and A. Tubis New off-line method for detecting spontaneous otoacoustic emissions in human subjects Hear. Res. 71 1993 170 182
71. F.F. Telischi, T. Mom, M. Agrama, B.B. Stagner, O. Ozdamear, A. Bustillo, and G.K. Martin Comparison of the auditory-evoked brainstem response wave I to distortion product otoacoustic emissions resulting from changes to inner ear blood flow Laryngoscope 109 1999 186 191
72. G.B. Todd, G.R. Serjeant, and M.R. Larson Sensorineural hearing loss in Jamaicans with sickle cell disease Acta Otolaryngol. 76 1973 268 272
73. L.J. Walker, A. Stuart, and W.B. Green Outer and middle ear status and distortion product otoacoustic emissions in children with sickle cell disease Am. J. Audiol. 13 2004 164 172
74. M.L. Whitehead, B.L. Lonsbury-Martin, and G.K. Martin Evidence for two discrete sources of 2f1-f2 distortion product otoacoustic emission in rabbit. II: Differential physiological vulnerability J. Acoust. Soc. Am. 92 1992 2662 2682
75. C. Zhang, W. Huang, and H. Song Expression of vascular cell adhesion molecule-1, alpha4-integrin and L-selectin during inner ear immunity reaction Acta Otolaryngol. 120 2000 607 614
76. P. Zorowka, H.J. Schmitt, H.E. Eckel, K.L. Lippert, W. Schonberger, and E. Merz Serial measurements of transient evoked otoacoustic emissions (TEOAEs) in healthy newborns and in newborns with perinatal infection Int. J. Pediatr. Otorhinolaryngol. 27 1993 245 254